Dynamic Advisor Solutions LLC Has $1.02 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Dynamic Advisor Solutions LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 28.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,231 shares of the company’s stock after selling 4,559 shares during the period. Dynamic Advisor Solutions LLC’s holdings in Colgate-Palmolive were worth $1,021,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CL. DGS Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 4.4% during the fourth quarter. DGS Capital Management LLC now owns 9,001 shares of the company’s stock worth $818,000 after acquiring an additional 376 shares during the period. Cottonwood Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $240,000. Exchange Traded Concepts LLC lifted its holdings in shares of Colgate-Palmolive by 13.9% in the fourth quarter. Exchange Traded Concepts LLC now owns 221,440 shares of the company’s stock valued at $20,131,000 after purchasing an additional 26,991 shares in the last quarter. CX Institutional boosted its position in shares of Colgate-Palmolive by 8.1% during the fourth quarter. CX Institutional now owns 4,539 shares of the company’s stock worth $413,000 after buying an additional 340 shares during the period. Finally, Impact Partnership Wealth LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $803,000. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Down 0.0 %

Shares of CL stock opened at $87.88 on Monday. Colgate-Palmolive has a 12-month low of $80.03 and a 12-month high of $109.30. The company has a market capitalization of $71.79 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The firm has a 50 day moving average price of $91.81 and a two-hundred day moving average price of $97.45. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CL. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $101.11.

View Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.